| Literature DB >> 26583113 |
Ruud P van Hove1, Inger N Sierevelt2, Barend J van Royen3, Peter A Nolte4.
Abstract
Surfaces of medical implants can be enhanced with the favorable properties of titanium-nitride (TiN). In a review of English medical literature, the effects of TiN-coating on orthopaedic implant material in preclinical studies were identified and the influence of these effects on the clinical outcome of TiN-coated orthopaedic implants was explored. The TiN-coating has a positive effect on the biocompatibility and tribological properties of implant surfaces; however, there are several reports of third body wear due to delamination, increased ultrahigh molecular weight polyethylene wear, and cohesive failure of the TiN-coating. This might be due to the coating process. The TiN-coating process should be optimized and standardized for titanium alloy articulating surfaces. The clinical benefit of TiN-coating of CoCrMo knee implant surfaces should be further investigated.Entities:
Mesh:
Substances:
Year: 2015 PMID: 26583113 PMCID: PMC4637053 DOI: 10.1155/2015/485975
Source DB: PubMed Journal: Biomed Res Int Impact factor: 3.411
Figure 1Flow diagram of the search process. Duplicate studies were excluded as well as studies of which there was no abstract. Studies on cardiovascular, dental, and neurological titanium-nitride coated implant material and other studies were excluded. Four studies on dental titanium-nitride coated implant material were included in this study in Section 3.1.
Preclinical studies on proliferation and differentiation of cells cultured on TiN-coated materials compared with control material.
| Study | Cell type | TiN-coated material | Proliferation | Differentiation |
|---|---|---|---|---|
| van Raay et al. (1995) [ | Human fibroblasts | Glass cover slips | ~ | |
| Groessner-Schreiber et al. (2003) [ | Mouse fibroblasts | cpTi | + | |
| Yeung et al. (2007) [ | Mouse osteoblasts | NiTi; SS; Ti6Al4V | + | |
| Annunziata et al. (2008) [ | BMSC | Ti6Al4V | ~ | ~ |
| Annunziata et al. (2011) [ | BM-MSC | TPS | ~ | ~ |
| Czarnowska et al. (2011) [ | Saos-2 | Ti6Al4V | ~ | ~ |
| Durual et al. (2011) [ | hOB | cpTi | + | ~ |
| Gordin et al. (2012) [ | hFOB 1.19 | cpTi; Ti6Al4V | ~ | |
| Rieder et al. (2012) [ | hOB | cpTi; SS | + | ~ |
| van Hove et al. (2013) [ | MC3T3-E1 | CoCrMo | + | ~ |
~: no difference between TiN-coated material and the control; +: higher on TiN-coated material than the control; −: lower on TiN-coated material than the control. TiN: titanium-nitride; BMSC: human bone marrow stromal cells; BM-MSC: human bone marrow mesenchymal stem cells; Saos-2: sarcoma osteogenic, human osteoblast-like cells; hOB: human primary osteoblasts; hFOB 1.19: human fetal-osteoblastic cell line; MC3T3-E1: mouse calvarial osteoblast-like cell; cp Ti: commercially pure titanium; NiTi: nickel-titanium; SS: stainless steel; Ti6Al4V: titanium-aluminum-vanadium alloy; TPS: titanium plasma sprayed.
Preclinical studies on wear of TiN-coated materials compared with control material.
| Study | Test | TiN-coated material | TiN-coating process | Control | Findings | TiN-coating related problems |
|---|---|---|---|---|---|---|
|
Coll and Jacquot (1988) [ | UHMWPE pin on disc | Ti6Al4V | AVID | Ti6Al4V | Reduction of UHMWPE wear | |
|
| ||||||
| Maurer et al. (1993) [ | Screws on plates | Ti6Al4V | PVD/PIII/NII | Ti6Al4V | Reduction of weight loss and metal release | |
|
| ||||||
| Venugopalan et al. (2000) [ | Pin-cylinder scratch test | Ti6Al4V | N | Ti6Al4V | Better scratch resistance | |
|
| ||||||
|
Hendry and Pilliar (2001) [ | Fretting test | Ti6Al4V | PVD | Ti6Al4V | No evidence of significant wear | Microparticles and pinholes |
|
| ||||||
| Komotori et al. (2001) [ | Multidirectional scratch testing | Ti6Al4V/SP-700 | AIP | TO-Ti6Al4V/SP-700 | More mechanical damage | Adhesive coating failure; pitting and blistering |
|
| ||||||
| Fisher et al. (2002) [ | MOM hip simulator | CoCrMo | AEPVD | CoCrMo | Lower wear | Relatively high wear inserts |
|
| ||||||
| Williams et al. (2003) [ | Multidirectional pin on plate | CoCrMo | AEPVD | CoCrMo | Fourfold increase of wear | Cohesive failure |
|
| ||||||
|
Gutmanas and Gotman (2004) [ | UHMWPE hip simulator | cpTi/Ti6Al4V | PIRAC | SS | Lower UHMWPE wear rate | |
|
| ||||||
| Fisher et al. (2004) [ | MOM hip simulator | CoCrMo | AEPVD | CoCrMo | Lower wear | Some localized damage |
|
| ||||||
| Galvin et al. (2008) [ | UHMWPE hip simulator | CoCrMo | AEPVD | CoCrMo | Higher UHMWPE volumetric wear rate | |
|
| ||||||
| Galetz et al. (2010) [ | Station-wheel-on-flat testing | CoCrMo | PVD | CoCrMo | No scratches | Polyethylene in pinholes |
|
| ||||||
| Kim et al. (2010) [ | Pin on disc | Ti6Al4V | AIP | Ti6Al4V | Lower wear | Higher wear of TiN compared with TiAlN |
|
| ||||||
| Lee et al. (2010) [ | UHMWPE pin on disc | SS | PIII | CoCrMo | Lower UHMWPE volumetric wear rate | |
∗: of titanium-nitride coated material compared with the control; TiN: titanium-nitride; UHMWPE: ultrahigh molecular weight polyethylene; MOM: metal-on-metal; SS: stainless steel; Ti6Al4V: titanium-aluminum-vanadium alloy; TO-Ti6Al4V: titanium-oxide coated Ti6Al4V; SP-700: Ti4.5Al3V2Fe2Mo, titanium-aluminum-vanadium-iron-molybdenum alloy; CoCrMo: cobalt-chromium-molybdenum alloy; cp Ti: commercially pure titanium; TiAlN: titanium-aluminum-nitride coating; PIII: plasma immersion ion implantation; AIP: arc ion plating; AVID: arc vapor ion deposition; PVD: physical vapor deposition; NII: nitrogen ion implantation; N: nitrogen diffusion hardening; AEPVD: arc evaporative physical vapor deposition; PIRAC: powder immersion reaction assisted coating.
Clinical studies on survival of TiN-coated orthopaedic implants.
| Study | Type | Prosthesis | TiN-coated material | Number | Fixation | Follow-up | Survival | Reasons for revision |
|---|---|---|---|---|---|---|---|---|
|
Buechel and Pappas (1992) [ | Cohort | TAP | Ti6Al4V | 14 | Cementless | 15 (5–24) | 100% | None |
|
| ||||||||
| Massoud et al. (1997) [ | Cohort | THP | Ti nos | 16 | Cemented | 26 | 56% | Aseptic loosening |
|
| ||||||||
| Buechel et al. (2003) [ | Cohort | TAP | Ti6Al4V | 50 | Cementless | 60 (24–120) | 93.5% | Malalignment; PE wear; component subsidence |
|
| ||||||||
| Buechel et al. (2004) [ | Cohort | THP | Ti6Al4V | 130 | Cementless | 77 (27–134) | 95.5% | Aseptic loosening; bearing dissociation |
|
| ||||||||
|
Buechel and Pappas (2011) [ | Cohort | RHP | Ti6Al4V | 60 | Cementless | 36 (8–70) | 91.8% | Not specified |
|
| ||||||||
| Mohammed et al. (2014) [ | Cohort | TKP | CoCrMo | 305 | Cementless | 79 (36–122) | 95.1% | Prosthetic fractures; aseptic loosening; alignment |
|
| ||||||||
| van Hove et al. (2015) [ | RCT | TKP | CoCrMo | 50 | Cementless | 60 | 96% | Aseptic loosening |
All prosthetic joint articulations were TiN-coated implant material to UHMWPE. Follow-up is presented as mean (range) in months. RCT: randomized clinical trial; TAP: total ankle prosthesis; THP: total hip prosthesis; RHP: resurfacing total hip prosthesis; TKP: total knee prosthesis; Ti6Al4V: titanium-aluminum-vanadium alloy; CoCrMo: cobalt-chromium-molybdenum alloy; Ti nos: titanium not otherwise specified.